Skip to main content
SpringerLink
Log in

Medication Management

  • Chapter
  • First Online:
Trigeminal Nerve Pain

  • 736 Accesses

Abstract

Pain in the trigeminal nerve distribution can be caused by multiple etiologies. There are many pharmacologic options for treating pain, and each should be evaluated for appropriateness in a patient, taking into account the evidence for success, side effect profile, dosing schedule, and availability. While these medications have been primarily studied in classic trigeminal neuralgia, they are also used for medical management of symptomatic trigeminal neuralgia if surgical intervention is not indicated or as an intervention to avoid surgery. Other etiologies, such as painful trigeminal neuropathy, burning mouth syndrome, and postherpetic neuralgia may also respond to these medications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbamazepine (Tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 1996;29:265–7.

    Article  Google Scholar 

  2. Cruccu G, Gronseth G, Alksne J, Argoff C, Brainin M, Burchiel K, et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2008;15:1013–28.

    Article  CAS  PubMed  Google Scholar 

  3. Gomez-Arguelles JM, Dorado R, Sepulveda A, Herrera FG, Arrojo E, Aragón CR, Huete C, Terrón B, Anciones B. Oxcarbazepine monotherapy incarbamazepine-unresponsive trigeminalneuralgia. J Clin Neurosci. 2008;15(5):516–9.

    Article  CAS  PubMed  Google Scholar 

  4. Beydoun A. Clinical use of tricyclic anticonvulsants in painful neuropathies and bipolar disorders. Epilepsy Behav. 2002;3S(3):S18–22.

    Article  Google Scholar 

  5. Fromm GH, Chattha AS, Terrence CF, Glass JD. Role of inhibitory mechanisms in trigeminal neuralgia. Neurology. 1981;31(6):683–7.

    Article  CAS  PubMed  Google Scholar 

  6. Fromm GH, Terrence CF, Chattha AS. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up. Ann Neurol. 1984;15(3):240–4.

    Article  CAS  PubMed  Google Scholar 

  7. Zakrzewska JM, Chaudry Z, Nurmikko TJ, Patton DW, Mullens EL. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double blind placebo controlled crossover trial. Pain. 1997;73(2):223–30.

    Article  CAS  PubMed  Google Scholar 

  8. Lechin F, van der Dijs B, Lechin ME, Amat J, Lechin AE, Cabrera A, et al. Pimozide therapy for trigeminal neuralgia. Arch Neurol. 1989;46(9):960–3.

    Article  CAS  PubMed  Google Scholar 

  9. Jorns TP, Johnston A, Zakrsewska JM. Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia. J Neurol. 2009;16(6):740–4.

    CAS  Google Scholar 

  10. Mitsikostas DD, Pantes GV, Avramidis TG, Karageorgiou KE, Gatzonis SD, Stathis PG, et al. An observational trial to investigate the efficacy and tolerability of levetiracetam in trigeminal neuralgia. Headache. 2010;50(8):1371–7.

    Article  PubMed  Google Scholar 

  11. Vogl C, Mochida S, Wolff C, Whalley B, Stephens G. The synaptic vesicle glycoprotein SA ligand levetiracetam inhibits presynaptic Ca2+ channels through an intracellular pathway. Mol Pharmacol. 2012;82(2):199–208.

    Article  CAS  PubMed  Google Scholar 

  12. Ta PCP, Dinh HQ, Nguyen K, Lin S, Ong YL, Ariyawardana A. Efficacy of gabapentin in the treatment of trigeminal neuralgia: a systemic review of randomized controlled trials. J Investig Clin Dent. 2019;10(4):e12448.

    Article  PubMed  Google Scholar 

  13. Debta FM, Ghom AG, Shah JS, Debta P. A comparative study between oxcarbazepine and gabapentin regarding therapeutic efficiency and tolerability in the treatment of trigeminal neuralgia. J Indian Acad Oral Med Radiol. 2010;22(1):10–7.

    Article  Google Scholar 

  14. Lemos L, Flores S, Oliveira P, Almeida A. Gabapentin supplemented with ropivacaine block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone. Clin J Pain. 2008;24(1):64–75.

    Article  PubMed  Google Scholar 

  15. Cheshire WP. Defining the role for gabapentin in the treatment of trigeminal neuralgia: a retrospective study. J Pain. 2002;3(2):137–42.

    Article  PubMed  Google Scholar 

  16. Hamasaki T, Yano S, Nakamura K, Yamada K. Pregabalin as a salvage preoperative treatment for refractory trigeminal neuralgia. J Clin Neurosci. 2018;47:240–4.

    Article  CAS  PubMed  Google Scholar 

  17. Rustagi A, Roychoudhury A, Bhutia O, Trikha A, Srivastava MV. Lamotrigine versus pregabalin in the management of refractory trigeminal neuralgia: a randomized open label crossover trial. J Maxillofac Oral Surg. 2014;13(4):409–18.

    Article  PubMed  Google Scholar 

  18. Court JE, Kase CS. Treatment of tic douloureux with a new anticonvulsant (clonazepam). J Neurol Neurosurg Psychiatry. 1976;39(3):297–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Peiris JB, Perera GL, Devendra SV, Lionel ND. Sodium valproate in trigeminal neuralgia. Med J Aust. 1980;2(5):278.

    Article  CAS  PubMed  Google Scholar 

  20. Cheshire WP. Fosphenytoin: an intravenous option for the management of acute trigeminal neuralgia crisis. J Pain Symptom Manag. 2001;21(6):506–10.

    Article  CAS  Google Scholar 

  21. McCleane GJ. Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double blinded, placebo-controlled, crossover study. Anesth Analg. 1999;89(4):985–8.

    CAS  PubMed  Google Scholar 

  22. Di Stefano G, Maarbjerg S, Truini A. Trigeminal neuralgia secondary to multiple sclerosis: from the clinical picture to the treatment options. J Headache Pain. 2019;20(1):20.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Hadley GR, Gayle JA, Ripoll J, Jones MR, Argoff CE, Kaye RJ, et al. Post-herpetic neuralgia: a review. Curr Pain Headache Rep. 2016;20(3):17.

    Article  PubMed  Google Scholar 

  24. Zhang M, Gao CX, Ma KT, Li L, Dai ZG, Wang S, et al. A meta-analysis of therapeutic efficacy and safety of gabapentin in the treatment of postherpetic neuralgia from randomized controlled trials. Biomed Res Int. 2018; https://doi.org/10.1155/2018/7474207.

  25. Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in post-herpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Pain. 2003;104(1–2):323–31.

    Article  CAS  PubMed  Google Scholar 

  26. Raja SN, Haythornthwaite JA, Pappagallo M, Clark MR, Travison TG, Sabeen S, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2002;59(7):1015–21.

    Article  CAS  PubMed  Google Scholar 

  27. Lauria G, Majorana A, Borgna M, Lombardi R, Penza P, Padovani A, et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain. 2005;115(3):332–7.

    Article  PubMed  Google Scholar 

  28. Wood PB. Role of central dopamine in pain and analgesia. Expert Rev Neurother. 2008;8(5):781–97.

    Article  CAS  PubMed  Google Scholar 

  29. Stuginski-Barbosa J, Rodrigues GGR, Bigal ME, Speciali JG. Burning mouth syndrome responsive to pramipexol. J Headache Pain. 2008;9(1):43–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Cornelissen P, van Kleef M, Mekhail N, Day M, van Zundert J. Evidence-based interventional pain medicine according to clinical diagnoses. 3. Persistent idiopathic facial pain. Pain Pract. 2009;9(6):443–8.

    Article  PubMed  Google Scholar 

  31. Volcy M, Rapoport AM, Tepper SJ, Sheftell FD, Bigal ME. Persistent idiopathic facial pain responsive to topiramate. Cephalalgia. 2006;26(4):489–91.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

    Elizabeth Lake

Authors
  1. Elizabeth Lake
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elizabeth Lake .

Editor information

Editors and Affiliations

  1. Department of Anesthesiology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

    Alaa Abd-Elsayed

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lake, E. (2021). Medication Management. In: Abd-Elsayed, A. (eds) Trigeminal Nerve Pain. Springer, Cham. https://doi.org/10.1007/978-3-030-60687-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-60687-9_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-60686-2

  • Online ISBN: 978-3-030-60687-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation